Rifaximin (Xifaxan)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • July 22, 2022; May 2018; June 2017; June 2015; October 2013; December 2011; April 2010; December 2006.
• Initially developed
  • September 2006